Introduction
A vaccine best known for preventing a painful skin condition may be doing far more for older adults than expected.
The Findings
New research shows that older adults who received the Shingrix shingles vaccine were 24% less likely to be diagnosed with dementia over a four-year follow-up period compared with those who did not receive it. The scale of the reduction has caught the attention of neurologists and public health researchers alike.
Why the Link Might Exist
Scientists believe chronic viral reactivation, including of the varicella-zoster virus that causes shingles, may contribute to long-term neuroinflammation linked to cognitive decline. By preventing shingles outbreaks, the vaccine may indirectly reduce this inflammatory burden on the brain.
What Experts Are Saying
While researchers caution that this is an observational link rather than definitive proof of causation, the consistency of similar findings across multiple studies is strengthening the case for shingles vaccination as a potential piece of the dementia-prevention puzzle.
What It Means for You
Health authorities already recommend the shingles vaccine for most adults over 50. This latest evidence gives an additional reason for older adults to consider getting vaccinated, alongside its established benefits for preventing shingles and related nerve pain.
Shingles Vaccine Linked to 24% Lower Risk of Dementia in Older Adults
Tonerland Team • August 22, 2026 • 5 min read
A large new study adds to growing evidence that the Shingrix vaccine may protect brain health well beyond simply preventing shingles.
Why It Matters
“ Power your business with innovation that works as hard as you do. Explore the new HP LaserJet Enterprise Series – only at Tonerland.
